Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3707630013 | Product containing clobetasol and neomycin and nystatin in cutaneous dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3707631012 | Clobetasol- and neomycin- and nystatin-containing product in cutaneous dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing clobetasol and neomycin and nystatin in cutaneous dose form (medicinal product form) | Is a | Product containing neomycin in cutaneous dose form (medicinal product form) | true | Inferred relationship | Some | ||
| Product containing clobetasol and neomycin and nystatin in cutaneous dose form (medicinal product form) | Has active ingredient | Nystatin (substance) | true | Inferred relationship | Some | 2 | |
| Product containing clobetasol and neomycin and nystatin in cutaneous dose form (medicinal product form) | Is a | Product containing clobetasol in cutaneous dose form (medicinal product form) | true | Inferred relationship | Some | ||
| Product containing clobetasol and neomycin and nystatin in cutaneous dose form (medicinal product form) | Is a | Nystatin-containing product in cutaneous dose form | true | Inferred relationship | Some | ||
| Product containing clobetasol and neomycin and nystatin in cutaneous dose form (medicinal product form) | Has active ingredient | Clobetasol (substance) | true | Inferred relationship | Some | 3 | |
| Product containing clobetasol and neomycin and nystatin in cutaneous dose form (medicinal product form) | Has manufactured dose form | Cutaneous dose form | true | Inferred relationship | Some | ||
| Product containing clobetasol and neomycin and nystatin in cutaneous dose form (medicinal product form) | Has active ingredient | Neomycin (substance) | true | Inferred relationship | Some | 1 | |
| Product containing clobetasol and neomycin and nystatin in cutaneous dose form (medicinal product form) | Is a | Product containing clobetasol and neomycin and nystatin (medicinal product) | true | Inferred relationship | Some | ||
| Product containing clobetasol and neomycin and nystatin in cutaneous dose form (medicinal product form) | Plays role | Antibacterial therapeutic role (role) | false | Inferred relationship | Some | ||
| Product containing clobetasol and neomycin and nystatin in cutaneous dose form (medicinal product form) | Plays role | Antifungal therapeutic role (role) | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Clobetasol and neomycin and nystatin only product in cutaneous dose form | Is a | True | Product containing clobetasol and neomycin and nystatin in cutaneous dose form (medicinal product form) | Inferred relationship | Some |
Reference Sets
FHIR